The European Union traditional herbal

medicinal registered instruction for

Chinese medicine bring opportunities

internationalization

Xinhua net

How to let the blindly, and by the European proprietary Chinese medicine registered with drug identity into local mainstream medicine market, sold to europeans?

In China the medical scholars, enterprise delegates, the relevant government official on China northwest province of gansu province to discuss the problem of lanzhou, in order to further promote the traditional Chinese medicine of the Chinese national treasure internationalization.

Gansu province is China's traditional planting area first artificial province, the planting area in 2.5 million acres around. The province's "China time-honored brand" pharmaceutical enterprise, lanzhou Buddha Keats pharmaceutical Co., LTD. In June this year the eu member states to the Swedish national drug administration submitted an application for registration of proprietary Chinese medicines blindly and accepted. This is the first time China's traditional Chinese medicine in the European Union drug registration application.

The European Union in 2004 the European Union announced "traditional herbs, set of registered instructions" simple registration "program, and for the use of herbs were set the seven years of sales transition. To this year on April 30, seven years after expiration, the transition was formally implemented instructions.

Buddha kindness to the European Union pharmaceutical drug registration application, triggered in China, the Chinese medicine is the eu registered medical attention. Media attention in kindness pharmaceutical registration success of Buddha at the same time, also questioned why in the past seven years without a transitional period of traditional Chinese medicine through the eu registered.

China's state administration of traditional Chinese medicine director WangGuoJiang said: "because no patient was proprietary Chinese medicine in the European Union successfully registered in the short term, proprietary Chinese medicine will not be able to continue to export sales in the European Union, but the larger share of prepared and extract can still food or food supplements form sales."

Earlier, traditional Chinese medicine and Chinese medicine yinpian, Chinese herb extract is the same, is playing "cut", with food or food supplements form in the eu sales.

Since drugs identity not recognized, can't enter the mainstream medicine market, proprietary Chinese medicine in the eu market share has been very small. According to WangGuoJiang introduces, in 2010, China's traditional Chinese medicine to Europe exports to 250 million us dollars, including proprietary Chinese medicine only 4%, about $10 million.

Although in the past seven years for a variety of reasons, no case was Chinese medicine through drug registration to the European Union, but the European Union to the registration of the traditional Chinese medicine lanzhou plan in China more than people in the medical argues that the eu traditional herbal medicinal registration instructions of Chinese medicine to speed up the pace of international objectively provide opportunities. Editorial: LiuYangHe) (responsibility

WangGuoJiang said, and the ec drug registration instructions with the requirements of the "new directive, compared the" simple registration "program has greatly increased the proprietary Chinese medicine pharmaceutical registration form to the possibility of selling for traditional Chinese medicine, which objectively products to drug form entering the eu market provides an opportunity.

At present, the European Union is considered to be outside China in addition to the world's largest plant medicine market. Traditional Chinese medicine in the eu registered surface is the identity of the drug approval, and behind them is huge market potential.

Buddha Keats, deputy general manager SunYu pharmaceutical, said if the goodness of the flavour to the European Union, proprietary Chinese medicine by registered into a regular drug channel sales and open the market, sales are expected to its more than China's total exports of traditional Chinese medicine.

In addition, global concern American plant medicine in drug research, management and market, etc by European influence. In traditional Chinese medicine the European Union to the professionals of registered generally think that the eu registered success, for Chinese traditional medicine into the United States market open door, and for future in North America and global market sales will have a positive and far-reaching influence.

"Traditional Chinese medicine to the world, to enter the international market is the inevitable trend of the development of." Academician of Chinese academy of engineering WangLongDe said, "in traditional Chinese medicine pharmaceutical identity can get to countries in Europe and America market access and enter the international market, traditional Chinese medicine is one of the key problems of internationalization, also is our long-term focus."

SunYu said, if in the eu registered success, Buddha in the eu should not only kindness pharmaceutical set up sales center, also will organize experts to traditional Chinese medicine academic exchange, the training of sales personnel, and promote the traditional Chinese medicine, this undoubtedly conducive to the internationalization of Chinese medicine.

"The eu, traditional herbal medicinal registration instructions for the traditional Chinese medicine product to though of drug form into the eu market, but given an opportunity to more traditional Chinese medicine, especially the complex compound Chinese medicine composition by the European Union to drugs registered identity into the mainstream medicine market sales, the challenge is still very large, a long road.

Buddha said, ZhuRongZu kindness pharmaceutical general manager to tell europeans the effects of TCM, safety or not, how, what are the composition is not an easy thing, need to spend a huge scientific research into the human and financial resources, the risk is very big, this also is in the past seven years why not a case of a Chinese traditional medicine through the transition of the eu registered one important reason.

However, the accumulation of experience of the Buddha of Keats pharmaceutical now is expected to Chinese medicine in the eu registered zero breakthrough.

SunYu said domestic market, increasingly fierce competition, medicine price has been difficult to rise, and raw materials, labor, transportation costs in continuing to rise, go out to have a broader space. If the application for the eu's kindness registered the taste of the medicine, now or the price of five years ago factory, and raw material prices would have double.

In traditional Chinese medicine to discuss the registration of policy measures in the pharmaceutical industry experts say that the Chinese traditional medicine, to promote the internationalization of the whole industry, and industry upgrade to make Chinese medicine better go to the world. In the interactive process, in addition to its own efforts, the government should also give positive support.

WangLongDe said that, at present, China's export of Chinese herbal medicine, Chinese traditional medicine products still drink, plant extract etc YuanLiaoLei low value-added products, the thousands of years of Chinese medicine with Chinese traditional and traditional Chinese medicine resources superpower highly proportion. Looking forward to good use the new European Union directive, the opportunity to realize Chinese medicine in the international market brand and its value should be back.